Male circumcision and women's risk of incident chlamydial, gonococcal, and trichomonal infections

Sexually Transmitted Diseases

Volumn 35, Issue 7, 2008, Pages 689-695

  Turner, Abigail Norris ^a   Morrison, Charles S ^b   Padian, Nancy S ^c   Kaufman, Jay S ^a   Behets, Frieda M ^a   Salata, Robert A ^d   Mmiro, Francis A ^e   Chipato, Tsungai ^f   Celentano, David D ^g   Rugpao, Sungwal ^h   Miller, William C ^a  

^a IL   (United States)

^b RTI International   (United States)

^c RTI INTERNATIONAL   (United States)

^d CASE WESTERN RESERVE UNIVERSITY   (United States)

^e MAKERERE UNIVERSITY   (Uganda)

^f UNIVERSITY OF ZIMBABWE   (Zimbabwe)

^g JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^h CHIANG MAI UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CEFTRIAXONE; CIPROFLOXACIN; DOXYCYCLINE; ERYTHROMYCIN; KANAMYCIN; METRONIDAZOLE; NORFLOXACIN;

ADULT; ARTICLE; CHLAMYDIASIS; CIRCUMCISION; COMPARATIVE STUDY; CONFIDENCE INTERVAL; FEMALE; FOLLOW UP; GONORRHEA; HAZARD RATIO; HORMONAL CONTRACEPTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION RISK; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; POLYMERASE CHAIN REACTION; PROPORTIONAL HAZARDS MODEL; SEXUAL BEHAVIOR; SEXUALITY; SEXUALLY TRANSMITTED DISEASE; THAILAND; TRICHOMONIASIS; UGANDA; ZIMBABWE; ADOLESCENT; CHLAMYDIA TRACHOMATIS; DISEASE TRANSMISSION; MALE; PROSPECTIVE STUDY; RISK FACTOR; STATISTICS; WOMEN'S HEALTH;

ADOLESCENT; ADULT; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; CIRCUMCISION, MALE; FEMALE; GONORRHEA; HUMANS; MALE; PROSPECTIVE STUDIES; RISK FACTORS; SEXUAL PARTNERS; SEXUALLY TRANSMITTED DISEASES; THAILAND; TRICHOMONAS INFECTIONS; UGANDA; WOMEN'S HEALTH; ZIMBABWE;

EID: 50649117822     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e31816b1fcc     Document Type: Article

References (63)

1. Auvert B, Taljaard D, Lagarde E, et al. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: The ANRS 1265 Trial. PLoS Med 2005; 2: e298.
2. Bailey RC, Moses S, Parker CP, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: A randomised controlled trial. Lancet 2007; 369:643-56.
3. Gray RH, Kigozi G, Serwadda D, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: A randomised trial Lancet 2007; 369:657-666.
4. Castellsague X, Bosch FX, Munoz N, et al. Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners. N Engl J Med 2002; 346:1105-12.
5. Gray R, Wawer M, Thoma M, et al. Male circumcision and the risks of female HIV and sexually transmitted infections acquisition in Rakai, Uganda (abstract #128). Paper presented at: The 13th Conference on Retroviruses and Opportunistic Infections; 2006; Denver, CO.
6. Castellsague X, Peeling RW, Franceschi S, et al. Chlamydia trachomatis infection in female partners of circumcised and uncircumcised adult men. Am J Epidemiol 2005; 162:907-916.
7. Bailey RC, Neema S, Othieno R. Sexual behaviors and other HIV risk factors in circumcised and uncircumcised men in Uganda. J Acquir Immune Defic Syndr 1999; 22:294-301.
8. Dave SS, Fenton KA, Mercer CH, et al. Male circumcision in Britain: Findings from a national probability sample survey. Sex Transm Infect 2003; 79:499-500.
9. Aynaud O, Piron D, Bijaoui G, et al. Developmental factors of urethral human papillomavirus lesions: Correlation with circumcision. BJU Int 1999; 84:57-60.
10. Donovan B, Bassett I, Bodsworth NJ. Male circumcision and common sexually transmissible diseases in a developed nation setting. Genitourin Med 1994; 70:317-320.
11. Diseker RA III, Peterman TA, Kamb ML, et al. Circumcision and STD in the United States: Cross sectional and cohort analyses. Sex Transm Infect 2000; 76:474-479.
12. Smith GL, Greenup R, Takafuji ET. Circumcision as a risk factor for urethritis in racial groups. Am J Public Health 1987; 77:452-454.
13. Gray RH, Kiwanuka N, Quinn TC, et al. Male circumcision and HIV acquisition and transmission: Cohort studies in Rakai, Uganda Rakai Project Team. AIDS 2000; 14:2371-2381.
14. Gray R, Azire J, Serwadda D, et al. Male circumcision and the risk of sexually transmitted infections and HIV in Rakai, Uganda. AIDS 2004; 18:2428-2430.
15. Laumann EO, Masi CM, Zuckerman EW. Circumcision in the United States. Prevalence, prophylactic effects, and sexual practice. JAMA 1997; 277:1052-1057.
16. Lavreys L, Rakwar JP, Thompson ML, et al. Effect of circumcision on incidence of human immunodeficiency virus type 1 and other sexually transmitted diseases: A prospective cohort study of trucking company employees in Kenya. J Infect Dis 1999; 180:330-336.
17. Taylor PK, Rodin P. Herpes genitalis and circumcision. Br J Vener Dis 1975; 51:274-277.
18. Jansen HA, Morison L, Mosha F, et al. Geographical variations in the prevalence of HIV and other sexually transmitted infections in rural Tanzania. Int J STD AIDS 2003; 14:274-280.
19. Auvert B, Buve A, Ferry B, et al. Ecological and individual level analysis of risk factors for HIV infection in four urban populations in sub-Saharan Africa with different levels of HIV infection. AIDS 2001; 15(suppl 4):S15-S30.
20. Parker SW, Stewart AJ, Wren MN, et al. Circumcision and sexually transmissible disease. Med J Aust 1983; 2:288-290.
21. Cook LS, Koutsky LA, Holmes KK. Circumcision and sexually transmitted diseases. Am J Public Health 1994; 84:197-201.
22. Hart G. Factors associated with genital chlamydial and gonococcal infection in males. Genitourin Med 1993; 69:393-396.
23. Hooper RR, Reynolds GH, Jones OG, et al. Cohort study of venereal disease. I. The risk of gonorrhea transmission from infected women to men. Am J Epidemiol 1978; 108:136-144.
24. Reynolds SJ, Shepherd ME, Risbud AR, et al. Male circumcision and risk of HIV-1 and other sexually transmitted infections in India. Lancet 2004; 363:1039-1040.
25. Agot KE, Ndinya-Achola JO, Kreiss JK, et al. Risk of HIV-1 in rural Kenya: A comparison of circumcised and uncircumcised men. Epidemiology 2004; 15:157-163.
26. Spach DH, Stapleton AE, Stamm WE. Lack of circumcision increases the risk of urinary tract infection in young men. JAMA 1992; 267:679-681.
27. Serour F, Samra Z, Kushel Z, et al. Comparative periurethral bacteriology of uncircumcised and circumcised males. Genitourin Med 1997; 73:288-290.
28. Fergusson DM, Boden JM, Horwood LJ. Circumcision status and risk of sexually transmitted infection in young adult males: An analysis of a longitudinal birth cohort. Pediatrics 2006; 118:1971-1977.
29. van Howe RS. Genital ulcerative disease and sexually transmitted urethritis and circumcision: A meta-analysis. Int J STD AIDS 2007; 18:799 - 809.
30. Krieger JN, Verdon M, Siegel N, et al. Risk assessment and laboratory diagnosis of trichomoniasis in men. J Infect Dis 1992; 166:1362-1366.
31. Morrison CS, Richardson BA, Mmiro F, et al. Hormonal contraception and the risk of HIV acquisition. AIDS 2007; 21:85-95.
32. Hosmer DW, Lemeshow S. Applied Survival Analysis: Regression Modeling of Time to Event Data. New York: Wiley, 1999.
33. Turner AN, Morrison CS, Padian NS, et al. Men's circumcision status and women's risk of HIV acquisition in Zimbabwe and Uganda. AIDS 2007; 21:1779-1789.
34. Kleinbaum DG, Klein M. Survival Analysis: A Self-Learning Text, 2nd ed. New York, NY: Springer, 2005.
35. Maldonado G, Greenland S. Simulation study of confounder-selection strategies. Am J Epidemiol 1993; 138:923-936.
36. Holmes KK, Sparling PF, Mardh P, et al., eds. Sexually Transmitted Diseases, 3rd ed. New York: McGraw-Hill, Health Professions Division, 1999.
37. Kapiga SH, Lyamuya EF, Lwihula GK, et al. The incidence of HIV infection among women using family planning methods in Dar es Salaam, Tanzania. AIDS 1998; 12:75-84.
38. Quinn TC, Wawer MJ, Sewankambo N, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med 2000; 342:921-929.
39. Bailey RC, Plummer FA, Moses S. Male circumcision and HIV prevention: Current knowledge and future research directions. Lancet Infect Dis 2001; 1:223-231.
40. Weiss HA, Thomas SL, Munabi SK, et al. Male circumcision and risk of syphilis, chancroid, and genital herpes: A systematic review and meta-analysis. Sex Transm Infect 2006; 82:101-109; discussion 110.
41. Diseker RA III, Lin LS, Kamb ML, et al. Fleeting foreskins: The misclassification of male circumcision status. Sex Transm Dis 2001; 28:330-335.
42. Wynder EL, Licklider SD. The question of circumcision. Cancer 1960; 13:442-445.
43. Schlossberger NM, Turner RA, Irwin CE Jr. Early adolescent knowledge and attitudes about circumcision: Methods and implications for research. J Adolesc Health 1992; 13:293-297.
44. Brinton LA, Reeves WC, Brenes MM, et al. The male factor in the etiology of cervical cancer among sexually monogamous women. Int J Cancer 1989; 44:199-203.
45. Urassa M, Todd J, Boerma JT, et al. Male circumcision and susceptibility to HIV infection among men in Tanzania. AIDS 1997; 11:73-80.
46. Dunn JE Jr, Buell P. Association of cervical cancer with circumcision of sexual partner. J Natl Cancer Inst 1959; 22:749-764.
47. Terris M, Wilson F, Nelson JH Jr. Relation of circumcision to cancer of the cervix. Am J Obstet Gynecol 1973; 117:1056-1066.
48. Stern E, Lachenbruch PA. Circumcision information in a cancer detection center population. J Chronic Dis 1968; 21:117-124.
49. Lilienfeld AM, Graham S. Validity of determining circumcision status by questionnaire as related to epidemiological studies of cancer of the cervix. J Natl Cancer Inst 1958; 21:713-720.
50. Seed J, Allen S, Mertens T, et al. Male circumcision, sexually transmitted disease, and risk of HIV. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 8:83-90.
51. Williams BG, Lloyd-Smith JO, Gouws E, et al. The potential impact of male circumcision on HIV in Sub-Saharan Africa. PLoS Med 2006; 3:e262.
52. Wendell B, Werker E. Male circumcision and the impact of AIDS in Africa. Cambridge: Harvard University Department of Economics, 2004.
53. Measure DHS. Demographic and health surveys 2005. Available at: http://www.measuredhs.com. Accessed 25 May 2006.
54. Radonjic IV, Dzamic AM, Mitrovic SM, et al. Diagnosis of Trichomonas vaginalis infection: The sensitivities and specificities of microscopy, culture and PCR assay. Eur J Obstet Gynecol Reprod Biol 2006; 126:116-120.
55. Madico G, Quinn TC, Rompalo A, et al. Diagnosis of Trichomonas vaginalis infection by PCR using vaginal swab samples. J Clin Microbiol 1998; 36:3205-3210.
56. van der Pol B, Kraft CS, Williams JA. Use of an adaptation of a commercially available PCR assay aimed at diagnosis of chlamydia and gonorrhea to detect Trichomonas vaginalis in urogenital specimens. J Clin Microbiol 2006; 44:366-373.
57. Wendel KA, Erbelding EJ, Gaydos CA, et al. Trichomonas vaginalis polymerase chain reaction compared with standard diagnostic and therapeutic protocols for detection and treatment of vaginal trichomoniasis. Clin Infect Dis 2002; 35:576-580.
58. van der Pol B, Kwok C, Pierre-Louis B, et al. Trichomonas vaginalis infection and human immunodeficiency virus acquisition in African women. J Infect Dis, 2008; 197:548-554.
59. Livengood CH III, Wrenn JW. Evaluation of COBAS AMPLICOR (Roche): Accuracy in detection of Chlamydia trachomatis and Neisseria gonorrhoeae by coamplification of endocervical specimens. J Clin Microbiol 2001; 39:2928-2932.
60. Martin DH, Cammarata C, van der Pol B, et al. Multicenter evaluation of AMPLICOR and automated COBAS AMPLICOR CT/NG tests for Neisseria gonorrhoeae. J Clin Microbiol 2000; 38:3544-3549.
61. van der Pol B, Martin DH, Schachter J, et al. Enhancing the specificity of the COBAS AMPLICOR CT/NG test for Neisseria gonorrhoeae by retesting specimens with equivocal results. J Clin Microbiol 2001; 39:3092-3098.
62. Tabrizi SN, Chen S, Cohenford MA, et al. Evaluation of real time polymerase chain reaction assays for confirmation of Neisseria gonorrhoeae in clinical samples tested positive in the Roche Cobas Amplicor assay. Sex Transm Infect 2004; 80:68-71.
63. Farrell DJ. Evaluation of AMPLICOR Neisseria gonorrhoeae PCR using cppB nested PCR and 16S rRNA PCR. J Clin Microbiol 1999; 37:386-390.